Journal of Adolescent Health
Volume 35, Issue 6 , Pages 501-504 , December 2004

Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001

  • Sean Esteban McCabe, Ph.D., M.S.W.

      Affiliations

    • Substance Abuse Research Center, The University of Michigan, Ann Arbor, Michigan, USA
    • Corresponding Author InformationAddress correspondence to: Dr. Sean Esteban McCabe, Assistant Research Scientist, Substance Abuse Research Center, The University of Michigan, 475 Market Place, Suite D, Ann Arbor, Michigan 48108-1649 USA
    • ,
  • Christian J. Teter, Pharm.D., B.C.P.P.

      Affiliations

    • Substance Abuse Research Center, The University of Michigan, Ann Arbor, Michigan, USA
    • College of Pharmacy, The University of Michigan, Ann Arbor, Michigan, USA
    • ,
  • Carol J. Boyd, Ph.D., R.N.

      Affiliations

    • Substance Abuse Research Center, The University of Michigan, Ann Arbor, Michigan, USA
    • School of Nursing, The University of Michigan, Ann Arbor, Michigan, USA
    • ,
  • Sally K. Guthrie, Pharm.D., B.C.P.P.

      Affiliations

    • College of Pharmacy, The University of Michigan, Ann Arbor, Michigan, USA
    • Department of Women’s Studies, The University of Michigan, Ann Arbor, Michigan, USA
    • Department of Psychiatry, The University of Michigan, Ann Arbor, Michigan, USA

,Accepted 4 February 2004.

References 

  1. Goldman LS, Genel M, Bezman RJ, Slanetz PJ  Council on Scientific Affairs, American Medical Association . Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100–1107
  2. Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects (A review). Pharmacol Biochem Behav. 2001;68:611–627
  3. Johnston LD, O’Malley PM, Bachman JG. Monitoring the Future National Survey Results on Drug Use, 1975–2001, Volume I (Secondary School Students). Bethesda, MD: National Institute on Drug Abuse; 2002;
  4. Indiana Resource Prevention Center. ATOD use by Indiana children and adolescents. Available at: http://www.drugs.indiana.edu/drug_stats/youth2002/stats2002.html. Accessed July 1, 2003
  5. Klein-Schwartz W. Pediatric methylphenidate exposures (7-year experience of poison centers in the United States). Clin Pediatr. 2003;42:159–164
  6. Foley R, Mrvos R, Krenzelok EP. A profile of methylphenidate exposures. J Toxicol Clin Toxicol. 2000;38:625–630
  7. Jessor R, Donovan JE, Costa FM. Beyond Adolescence (Problem Behavior and Young Adult Development). Cambridge, UK: Cambridge University Press; 1991;
  8. Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old (Results from a commercially insured US sample). Pediatrics. 2003;111:237–243
  9. Lafever GB, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health. 1999;89:1359–1364
  10. Safer DJ, Malever M. Stimulant treatment in Maryland public schools. Pediatrics. 2000;106:533–539
  11. O’Malley PM, Bachman JG, Johnston LD. Reliability and consistency in self-reports of drug use. Int J Addict. 1983;18:805–824
  12. Johnston LD, O’Malley PM. Issues of validity and population coverage in student surveys of drug use. NIDA Res Monogr. 1985;57:31–54

PII: S1054-139X(04)00067-9

doi: 10.1016/j.jadohealth.2004.02.004

Journal of Adolescent Health
Volume 35, Issue 6 , Pages 501-504 , December 2004

Article Tools